Immunogenicity and therapeutic efficacy of a dual-component genetic cancer vaccine cotargeting carcinoembryonic antigen and HER2/neu in preclinical models.
about
Evolution of animal models in cancer vaccine developmentDNA vaccine for cancer immunotherapyA novel minigene scaffold for therapeutic cancer vaccinesCargo-delivery platforms for targeted delivery of inhibitor cargos against botulism.Superior Immunologic and Therapeutic Efficacy of a Xenogeneic Genetic Cancer Vaccine Targeting Carcinoembryonic Human Antigen.DNA vaccines, electroporation and their applications in cancer treatmentMC32 tumor cells acquire Ag-specific CTL resistance through the loss of CEA in a colon cancer modelImmunotherapy of cancers comes of age.Vaccine Design: Replication-Defective Adenovirus Vectors.
P2860
Q28080739-333EFFEA-1B44-4E1D-B64C-B41443E9E1BCQ28080919-6831CE06-4C95-4F41-A115-C8B697B103D4Q34418540-BE6AEC9E-2271-4438-83D8-6F029242A10CQ35542237-9548684A-4EDD-495E-B962-4C12825765AFQ35822301-65BE7CDC-81C2-4176-8B4C-BF11036B5368Q36256459-D5C01359-270A-4F0A-949B-6D1914778434Q36256568-1D482A86-7335-4405-B4F4-C5A47F168CB8Q40099075-33F609C8-D3C8-44D1-938D-22136434E1D9Q40801619-D804D5EA-8E6A-45DD-AE50-BCA0C0C3962D
P2860
Immunogenicity and therapeutic efficacy of a dual-component genetic cancer vaccine cotargeting carcinoembryonic antigen and HER2/neu in preclinical models.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunogenicity and therapeutic ...... ER2/neu in preclinical models.
@en
Immunogenicity and therapeutic ...... ER2/neu in preclinical models.
@nl
type
label
Immunogenicity and therapeutic ...... ER2/neu in preclinical models.
@en
Immunogenicity and therapeutic ...... ER2/neu in preclinical models.
@nl
prefLabel
Immunogenicity and therapeutic ...... ER2/neu in preclinical models.
@en
Immunogenicity and therapeutic ...... ER2/neu in preclinical models.
@nl
P2093
P2860
P356
P1433
P1476
Immunogenicity and therapeutic ...... HER2/neu in preclinical models
@en
P2093
Daniela Peruzzi
Gloria Koo
Luigi Aurisicchio
Nicola La Monica
Wei-Zen Wei
P2860
P304
P356
10.1089/HUM.2013.103
P577
2013-12-21T00:00:00Z